International Clinical Trial: A Study on the Pharmacokinetic Characteristics of Sugammadex in Antagonizing Residual Neuromuscular Blockade in Postoperative Renal Transplant Patients and Its Impact on Postoperative Renal Function

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115653) titled 'A Study on the Pharmacokinetic Characteristics of Sugammadex in Antagonizing Residual Neuromuscular Blockade in Postoperative Renal Transplant Patients and Its Impact on Postoperative Renal Function' on Dec. 29, 2025.

Study Type: Interventional study

Study Design: Cohort study

Primary Sponsor: Peking University Third Hospital

Condition: Kidney Transplantation

Intervention: Renal transplant recipient:Administer sugammadex to reverse neuromuscular blockade

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2022-09-04

Target Sample Size: Renal transplant recipient:10;Renal transpla...